Assignee
CHEMOTHERAPEUTISCHES FORSCHUNGSINSTITUT GEORG SPEYER HAUS
DE·10 granted patents·6 pending applications·52 citations·filing 1993–2024
Top patents by PatentIndex Score
16 records- 0191US9815908B2Chimeric antigen receptors with an optimized hinge regionCHEMOTHERAPEUTISCHES FORSCHUNGSINSTITUT GEORG-SPEYER-HAUS·Filed 2015·Granted Nov 14, 2017·11 cites·7 claims
- 0288US10351612B2Interleukin 15 as selectable marker for gene transfer in lymphocytesCHEMOTHERAPEUTISCHES FORSCHUNGSINSTITUT GEORG SPEYER HAUS·Filed 2016·Granted Jul 16, 2019·5 cites·7 claims
- 0384US10556969B2Chimeric antigen receptors with an optimized hinge regionCHEMOTHERAPEUTISCHES FORSCHUNGSINSTITUT GEORG SPEYER HAUS·Filed 2017·Granted Feb 11, 2020·3 cites·8 claims
- 0480US9920132B2Car-expressing NK-92 cells as cell therapeutic agentsCHEMOTHERAPEUTISCHES FORSCHUNGSINSTITUT GEORG SPEYER HAUS·Filed 2017·Granted Mar 20, 2018·4 cites·15 claims
- 0568US5861243AVaccine for protection against HIV infections, process for preparing same and their use as diagnostic and agent immunotherapeutic agentCHEMOTHERAPEUTISCHES FORSCHUNGSINSTITUT GEORG SPEYER HAUS·Filed 1997·Granted Jan 19, 1999·28 cites·19 claims
- 0662US2025333462A1Periostin compounds for the treatment of haematological complicationsCHEMOTHERAPEUTISCHES FORSCHUNGSINSTITUT GEORG SPEYER HAUS·Filed 2024·Application pending·0 cites
- 0761US2026069693A1Urolithins and t-cell mediated immune responseCHEMOTHERAPEUTISCHES FORSCHUNGSINSTITUT GEORG SPEYER HAUS·Filed 2023·Application pending·0 cites
- 0856US2024075036A1Therapeutic combinations including inhibitors of the p2x4 receptor for treating and preventing proliferative disordersCHEMOTHERAPEUTISCHES FORSCHUNGSINSTITUT GEORG SPEYER HAUS·Filed 2022·Application pending·0 cites
- 0956US2024174768A1Bispecific antibodies enhancing cell mediated immune responsesCHEMOTHERAPEUTISCHES FORSCHUNGSINSTITUT GEORG SPEYER HAUS·Filed 2022·Application pending·0 cites
- 1050US12162918B2Periostin compounds for the treatment of haematological complicationsCHEMOTHERAPEUTISCHES FORSCHUNGSINSTITUT GEORG SPEYER HAUS·Filed 2019·Granted Dec 10, 2024·0 cites·4 claims
- 1150US2018282427A1Car-expressing nk-92 cells as cell therapeutic agentsCHEMOTHERAPEUTISCHES FORSCHUNGSINSTITUT GEORG SPEYER HAUS·Filed 2018·Application pending·0 cites
- 1247US10550197B2CAR-expressing NK-92 cells as cell therapeutic agentsCHEMOTHERAPEUTISCHES FORSCHUNGSINSTITUT GEORG SPEYER HAUS·Filed 2015·Granted Feb 4, 2020·0 cites·11 claims
- 1344US12023353B2Methods and compounds for improved immune cell therapyCHEMOTHERAPEUTISCHES FORSCHUNGSINSTITUT GEORG SPEYER HAUS·Filed 2018·Granted Jul 2, 2024·0 cites·10 claims
- 1436US2019374618A1Fibronectin or ilk inhibitors for use in the treatment of leukemiaCHEMOTHERAPEUTISCHES FORSCHUNGSINSTITUT GEORG SPEYER HAUS·Filed 2017·Application pending·0 cites
- 1531US5965135AHIV-1 virus isolates of a subtype and its differential diagnosticsCHEMOTHERAPEUTISCHES FORSCHUNGSINSTITUT GEORG SPEYER HAUS·Filed 1993·Granted Oct 12, 1999·1 cites·4 claims
- 1629US6248328B1HIV-1 virus isolates of a subtype and its differential diagnostics, a vaccine against HIV-1 virus infections of this subtype and method of producing same, use of the HIV-1 virus isolatesCHEMOTHERAPEUTISCHES FORSCHUNGSINSTITUT GEORG SPEYER HAUS·Filed 1999·Granted Jun 19, 2001·0 cites·7 claims
Join the waitlist — get patent alerts
Get an alert when CHEMOTHERAPEUTISCHES FORSCHUNGSINSTITUT GEORG SPEYER HAUS files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →